190 related articles for article (PubMed ID: 27922109)
1. Regulation of hepcidin expression by inflammation-induced activin B.
Kanamori Y; Sugiyama M; Hashimoto O; Murakami M; Matsui T; Funaba M
Sci Rep; 2016 Dec; 6():38702. PubMed ID: 27922109
[TBL] [Abstract][Full Text] [Related]
2. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Canali S; Core AB; Zumbrennen-Bullough KB; Merkulova M; Wang CY; Schneyer AL; Pietrangelo A; Babitt JL
Endocrinology; 2016 Mar; 157(3):1146-62. PubMed ID: 26735394
[TBL] [Abstract][Full Text] [Related]
3. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
[TBL] [Abstract][Full Text] [Related]
4. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling.
Besson-Fournier C; Latour C; Kautz L; Bertrand J; Ganz T; Roth MP; Coppin H
Blood; 2012 Jul; 120(2):431-9. PubMed ID: 22611157
[TBL] [Abstract][Full Text] [Related]
5. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription.
Zumbrennen-Bullough KB; Wu Q; Core AB; Canali S; Chen W; Theurl I; Meynard D; Babitt JL
J Biol Chem; 2014 Aug; 289(34):23796-808. PubMed ID: 25002578
[TBL] [Abstract][Full Text] [Related]
7. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Liver Int; 2008 Nov; 28(9):1207-16. PubMed ID: 18397232
[TBL] [Abstract][Full Text] [Related]
8. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
9. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
[TBL] [Abstract][Full Text] [Related]
11. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.
Bloise E; Cassali GD; Ferreira MC; Ciarmela P; Petraglia F; Reis FM
J Dairy Sci; 2010 Oct; 93(10):4592-601. PubMed ID: 20854993
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.
Besson-Fournier C; Gineste A; Latour C; Gourbeyre O; Meynard D; Martin P; Oswald E; Coppin H; Roth MP
Blood; 2017 Jan; 129(4):533-536. PubMed ID: 27903526
[No Abstract] [Full Text] [Related]
13. The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.
Colucci S; Pagani A; Pettinato M; Artuso I; Nai A; Camaschella C; Silvestri L
Blood; 2017 Nov; 130(19):2111-2120. PubMed ID: 28864813
[TBL] [Abstract][Full Text] [Related]
14. Localization and cellular sources of activins in normal and fibrotic rat liver.
De Bleser PJ; Niki T; Xu G; Rogiers V; Geerts A
Hepatology; 1997 Oct; 26(4):905-12. PubMed ID: 9328312
[TBL] [Abstract][Full Text] [Related]
15. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
16. The regulation of hepcidin expression by serum treatment: requirements of the BMP response element and STAT- and AP-1-binding sites.
Kanamori Y; Murakami M; Matsui T; Funaba M
Gene; 2014 Nov; 551(2):119-26. PubMed ID: 25151311
[TBL] [Abstract][Full Text] [Related]
17. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
[TBL] [Abstract][Full Text] [Related]
18. Isolation of the canine inhibin βB subunit gene and characterization of signalling mediated by canine inhibin βB.
Sakota S; Shimokawa F; Funaba M; Murakami M
Cell Biochem Funct; 2021 Dec; 39(8):970-982. PubMed ID: 34382234
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice.
Steinbicker AU; Bartnikas TB; Lohmeyer LK; Leyton P; Mayeur C; Kao SM; Pappas AE; Peterson RT; Bloch DB; Yu PB; Fleming MD; Bloch KD
Blood; 2011 Oct; 118(15):4224-30. PubMed ID: 21841161
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
